Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression

This publication has 42 references indexed in Scilit:

• Lovastatin Induced Control of Blast Cell Growth in an Elderly Patient with Acute Myeloblastic Leukemia
  Leukemia & Lymphoma, 2001
• Increased proximal tubular cholesterol content: Implications for cell injury and “acquired cytoresistance”
  Kidney International, 1999
• Expression of Caveolin-1 in Human T Cell Leukemia Cell Lines
  Biochemical and Biophysical Research Communications, 1998
• Detection of High Incidence of H-RAS Oncogene Point Mutations in Acute Myelogenous Leukemia
  American Journal of Hematology, 1993
• N-ras Mutations in Acute Myelogenous Leukemia: A Review of the Current Literature and an update of the Southwest Oncology Group Experience
  Leukemia & Lymphoma, 1992
• PCR-SSCP: a simple and sensitive method for detection of mutations in the genomic DNA.
  Genome Research, 1991
• Regulation of the mevalonate pathway
  Nature, 1990
• Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms.
  Proceedings of the National Academy of Sciences, 1989
• The Oncogenic Activation of Human p21 ^ras by a Novel Mechanism
  Science, 1986
• Suppression of murine neuroblastoma growth in vivo by mevinolin, a competitive inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
  Journal of Clinical Investigation, 1985